JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas

Leukemia and Lymphoma

Volumn 47, Issue 2, 2006, Pages 313-314

  Lee, Jong Woo ^a   Soung, Young Hwa ^a   Kim, Su Young ^a   Nam, Suk Woo ^a   Park, Won Sang ^a   Lee, Jung Young ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

JAK2; Mutation; Non Hodgkin lymphoma; Oncogene

Indexed keywords

JANUS KINASE 2; PHENYLALANINE; VALINE;

ARTICLE; BIOASSAY; CONTROLLED STUDY; DATA ANALYSIS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 30644470844     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500271723     Document Type: Article

References (7)

1. Alas, S and Bonavida, B. (2003) Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis Clinical Cancer Research, 9, pp. 316 - 326.
2. Levine, R and Wadleigh, M and Cools, J and Ebert, B and Wernig, G and Huntly, B. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell, 7, pp. 387 - 397.
3. James, C and Ugo, V and Le Couedic, J and Staerk, J and Delhommeau, F and Lacout, C and (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature, 434, pp. 1144 - 1148.
4. Steensma, D and Dewald, G and Lasho, T and Powell, H and McClure, R and Levine, R and (2005) The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both 'atypical' myeloproliferative disorders and the myelodysplastic syndrome, Blood, 106, pp 1207-1209
5. Gschwind, A and Fischer, O and Ullrich, A. (2004) The discovery of receptor tyrosine kinases: Targets for cancer therapy Natural Reviews in Cancer, 4, pp. 361 - 370.
6. Wessendorf, S and Schwaenen, C and Kohlhammer, H and Kienle, D and Wrobel, G and Barth, T and (2003) Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization Oncogene, 22, pp. 1425 - 1429.
7. Reiter, A and Walz, C and Watmore, A and Schoch, C and Blau, I and Schlegelberger, B and (2005) The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2 Cancer Research, 65, pp. 2662 - 2667.